Microfluidics Market by Material (Glass-based, Polymer-based, Silicon-based), Component (Micro Needle, Micro Pump, Microfluidic Chip), Application, End User - Global Forecast 2024-2030

Microfluidics Market by Material (Glass-based, Polymer-based, Silicon-based), Component (Micro Needle, Micro Pump, Microfluidic Chip), Application, End User - Global Forecast 2024-2030

The Microfluidics Market size was estimated at USD 25.53 billion in 2023 and expected to reach USD 31.84 billion in 2024, at a CAGR 25.37% to reach USD 124.31 billion by 2030.

Microfluidics is a multidisciplinary scientific field that deals with the precise control, manipulation, and analysis of fluids at a microscale level, typically in microliters to picoliters. Microfluidics integrates principles from diverse disciplines such as physics, engineering, chemistry, and biology to facilitate operations on small volumes of fluids using microfabricated devices featuring channels with dimensions ranging from tens to hundreds of micrometers. Increasing global investments in life sciences research have accelerated the demand for innovative tools and technologies. Microfluidic devices offer advantages such as high throughput screening capabilities and precise control over fluid handling at low volumes, making them attractive tools for researchers. Advances in healthcare infrastructure focusing on precision medicine have also contributed to an increased adoption of microfluidic technologies for diagnostic purposes. However, the complexity associated with designing, fabricating, and integrating microfluidic devices into current laboratory workflows and standardization issues arising due to different fabrication methods significantly impedes the usage of microfluidics. In addition, manufacturers focus on developing wearable diagnostic devices that employ microfluidic technologies to monitor patients' health in real-time.

Regional Insights

In the Americas, the United States and Canada emerged as key players in the microfluidics market due to their robust healthcare infrastructure and strong focus on research, which has led to increased investment from the public and private sectors. The National Institutes of Health (NIH) invests heavily in microfluidics research to advance personalized medicine and develop innovative diagnostic solutions. Countries such as China, Japan, and India showcase immense growth potential in microfluidics in the Asia-Pacific region. In China, numerous research institutions backed by government initiatives focus on developing novel microfluidic platforms for applications such as clinical diagnostics and environmental monitoring. European Union (EU) countries contribute significantly to developing microfluidics technologies, with numerous academic institutions working closely with industries for commercialization. The MEA region is developing interest in adopting cutting-edge medical technologies, including microfluidics, for diagnostic purposes. Countries, including Saudi Arabia and the UAE, have invested in state-of-the-art healthcare facilities that utilize advanced tools such as lab-on-a-chip systems for rapid disease detection.

Market Insights

• Market Dynamics
  
  The market dynamics represent an ever-changing landscape of the Microfluidics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
    • Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
    • Potential Applications of Drug Delivery using Microfluidics
    • Market Restraints
      • Complicated and Time-Consuming Regulatory Approval Process
      • Market Opportunities
        • Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
        • Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
        • Market Challenges
          • Integration of Microfluidics with Existing Workflows
          • Market Segmentation Analysis
            • Material: Increasing use of glass and silicon-based materials for microfluidic devices
            • Component: Adoption of microneedles and pumps for minimal risk of infection
            • Application: Significant application of microfluidic devices in IVD and therapeutics
            • End User: Emerging use of microfluidics in research organizations and hospitals & diagnostics centers
            • Market Disruption Analysis
            • Porter’s Five Forces Analysis
            • Value Chain & Critical Path Analysis
            • Pricing Analysis
            • Technology Analysis
            • Patent Analysis
            • Trade Analysis
            • Regulatory Framework Analysis
            FPNV Positioning Matrix
            
            The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Microfluidics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
            
            Market Share Analysis
            
            The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Microfluidics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
            
            Recent Developments
            • Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform
              
              Astraveus SAS, an innovator in cell and gene therapy (CGT) manufacturing, has emerged from stealth with USD 18.26 million Series Seed financing. The funding round was led by AdBio Partners, co-syndicated with M Ventures, Johnson & Johnson Innovation – JJDC Inc., and Bpifrance Large Venture. Astraveus leverages microfluidic cell foundries known as the Lakhesys platform to enhance CGT manufacturing processes. The Lakhesys system employs deep process optimization and single-use microfluidic bioprocessors to optimize CGT outcomes while minimizing resource utilization.
              
              Bio-Techne to acquire Swiss spatial biology firm Lunaphore
              
              Bio-Techne, a major player in microfluidics, announced its recent acquisition of Lunaphore, a Swiss-based developer of automated spatial biology products. Lunaphore's microfluidic technology offers precise and hyper plex proteomic and transcriptomic biomarkers for tumors and other tissues. This innovative technology provides the necessary data for discovering and developing diagnostic tools in the fields of immunology, immuno-oncology, and neuroscience. By leveraging Lunaphore's advanced solutions, Bio-Techne aims further to advance research and development in these critical areas.
              
              CellFE Announces Launch of Novel Microfluidic Cellular Engineering Platform at ASGCT 2023 Annual Meeting
              
              CellFE Inc., a microfluidics company, launched its Infinity Mtx cellular engineering platform for commercial use. This platform utilizes rapid cell compression and re-expansion techniques to introduce target payloads into cells effectively. The advantages of this platform are that it yields high quantities of edited cells, reduces recovery and expansion times, facilitates efficient uptake of various payloads, and lowers manufacturing expenses. By leveraging these capabilities, CellFE Inc. aims to revolutionize the field of cell therapy and contribute to the development of innovative treatments.
            Strategy Analysis & Recommendation
            
            The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Microfluidics Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
            
            Key Company Profiles
            
            The report delves into recent significant developments in the Microfluidics Market, highlighting leading vendors and their innovative profiles. These include Abaxis, Inc., Abbott Laboratories, AbCellera Biologics Inc., Achira Labs Pvt. Ltd., Agilent Technologies, Inc., Ascent Bio-Nano Technologies, Inc., Bio-Rad Laboratories, Inc., BioFluidica, Biosurfit SA, Camozzi Automation S.p.A., Cellix Limited, Danaher Corporation, Dolomite Microfluidics, Elvesys Group, Fluidigm Corporation by Standard BioTools Inc., Fluigent S.A., Idex Corporation, Illumina, Inc., IMT Masks and Divisions AG, Koninklijke Philips N.V., Micropoint Bioscience, Inc., Mission Bio, Inc., NanoCellect Biomedical., OPKO Health, Inc., Parker-Hannifin Corporation, PerkinElmer Inc., Quidel Corporation, SMC Corporation, Sphere Fluidics Limited, and Thermo Fisher Scientific, Inc..
            
            Market Segmentation & Coverage
            
            This research report categorizes the Microfluidics Market to forecast the revenues and analyze trends in each of the following sub-markets:
            • Material
              • Glass-based
              • Polymer-based
              • Silicon-based
              • Component
                • Micro Needle
                • Micro Pump
                • Microfluidic Chip
                • Application
                  • In-Vitro Diagnostics
                    • Clinical Diagnostics
                    • Point-Of-Care Testing
                    • Veterinary Diagnostics
                    • Pharmaceutical & Life Science Research
                      • Lab Analytics
                        • Capillary Electrophoresis
                        • Cell-based Assays
                        • Genomic analysis
                        • Proteomic Analysis
                        • Microdispensing
                        • Microreaction
                        • Therapeutics
                          • Drug Delivery
                          • Wearable Devices
                          • End User
                            • Academic & Research Institutes
                            • Hospitals & Diagnostic Centers
                            • Pharmaceutical & Biotechnology Companies
                            • Region
                              • Americas
                                • Argentina
                                • Brazil
                                • Canada
                                • Mexico
                                • United States
                                  • California
                                  • Florida
                                  • Illinois
                                  • New York
                                  • Ohio
                                  • Pennsylvania
                                  • Texas
                                  • Asia-Pacific
                                    • Australia
                                    • China
                                    • India
                                    • Indonesia
                                    • Japan
                                    • Malaysia
                                    • Philippines
                                    • Singapore
                                    • South Korea
                                    • Taiwan
                                    • Thailand
                                    • Vietnam
                                    • Europe, Middle East & Africa
                                      • Denmark
                                      • Egypt
                                      • Finland
                                      • France
                                      • Germany
                                      • Israel
                                      • Italy
                                      • Netherlands
                                      • Nigeria
                                      • Norway
                                      • Poland
                                      • Qatar
                                      • Russia
                                      • Saudi Arabia
                                      • South Africa
                                      • Spain
                                      • Sweden
                                      • Switzerland
                                      • Turkey
                                      • United Arab Emirates
                                      • United Kingdom
                                      
                                      
                                      Please Note: PDF & Excel + Online Access - 1 Year